Research

Hormonal

In nonalcoholic fatty liver disease (NAFLD), lipotoxic hepatocytes release exosomes enriched with miR-192-5p, which activates pro-inflammatory M1 macrophages by inhibiting the Rictor/Akt/FoxO1 signaling pathway, thereby driving hepatic inflammation and disease progression.

This research highlights that liver fat accumulation (lipotoxicity) actively sends inflammatory signals to immune cells in the liver, worsening NAFLD. The primary actionable insight is that reducing hepatic fat (through caloric restriction, metabolic improvement, or specific dietary changes) may interrupt this exosomal miR-192-5p signaling, thereby reducing macrophage-driven inflammation and slowing disease progression.

ModerateSupportsMEDIUM confidence
Hepatocyte-derived exosomal miR-192–5p plays a critical role in the activation of proinflammatory macrophages and disease progression of NAFLD via modulating Rictor/Akt/FoxO1 signaling.
Xiaolin Liu et al. · Hepatology · 2019

Why this rating

The study combines human clinical correlation with in vitro and in vivo animal models, providing strong mechanistic evidence but lacking direct human interventional trials.

Source

Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease

Xiaolin Liu et al. · Hepatology · 2019

DOI 10.1002/hep.31050

mechanism_only · n=85Cited 320×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →